Last update 28 Jun 2025

IVB-102

Overview

Basic Info

Drug Type
AAV based gene therapy
Synonyms
IVB 102, IVB102
Target
XLRS1
Action
modulators
Mechanism
XLRS1 modulators(Retinoschisin modulators)
Therapeutic Areas
Congenital DisordersEye DiseasesOther Diseases
Active Indication
Retinoschisis
Inactive Indication-
Originator Organization
Beijing innovec Pharmaceutical Technology Co., Ltd.Beijing innovec Pharmaceutical Technology Co., Ltd.
Active Organization
Beijing innovec Pharmaceutical Technology Co., Ltd.Beijing innovec Pharmaceutical Technology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
RegulationOrphan Drug (United States), Rare Pediatric Disease (United States)
Login to view timeline

Related

1
Clinical Trials associated with IVB-102
NCT06289452
/ Active, not recruitingEarly Phase 1
An Open-label, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IVB102 Injection in Subjects With X-linked Retinoschisis (XLRS)
100 Clinical Results associated with IVB-102
Login to view more data
100 Translational Medicine associated with IVB-102
Login to view more data
100 Patents (Medical) associated with IVB-102
Login to view more data
100 Deals associated with IVB-102
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
RetinoschisisPhase 1
China
Beijing innovec Pharmaceutical Technology Co., Ltd.Beijing innovec Pharmaceutical Technology Co., Ltd.
08 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free